De tre undersøgelser viste, at CYSTAGON forsinker nyreproblemer og behovet for dialyse eller nyretransplantation, når behandlingen påbegyndes i en tidlig alder hos patienter med gode nyrefunktioner.
The three studies have shown that CYSTAGON delays kidney problems, and the need for dialysis or renal transplantation when treatment is started at an early age in patients with good kidney function.